abstract
The applicability of Raman imaging for pharmaceutics production ranges from the characterization of phar-maceutical formulations, kinetic processes in drug delivery to the rapid detection and identification of coun-terfeit drugs/contaminants. Acetaminophen (Paracetamol, APAP) is an analgesic and antipyretic drug and one of the most consumed medicines worldwide. On the other hand, the compound 4-aminophenol (4-AP) is a hy-drolytic product of APAP with nephrotoxicity and teratogenic effects. In this work, we have explored for the first time Raman imaging methods to characterize the main components of commercial APAP tablets (APAP-tablets) and to inquire about the potential of this optical technique to identify 4-AP in APAP tablets, which have been previously spiked with such contaminant. The laboratorial treated APAP-tablet samples were subjected to different temperature, humidity and sunlight exposure conditions, mimicking storage conditions, and then the Raman spectra and images were collected to monitor changes that might occur in those conditions. Although the lower limit of detection of 4-AP in APAP-tablets is above the minimum levels established by Pharmacopoeias (0.005 %), this research demonstrates that Raman imaging still allows the detection of small amounts of the contaminant, thus opening perspectives for exploring this technique for characterizing APAP products.
keywords
ACETYL-P-AMINOPHENOL; SPECTROPHOTOMETRIC DETERMINATION; PHARMACEUTICAL FORMULATIONS; RAPID ASSAY; SPECTROSCOPY; QUALITY; ACETAMINOPHEN; DEGRADATION; SURFACE; DRUG
subject category
Chemistry; Spectroscopy
authors
Fateixa, S; Mulandeza, O; Nogueira, HIS; Trindade, T
our authors
Projects
CICECO - Aveiro Institute of Materials (UIDB/50011/2020)
CICECO - Aveiro Institute of Materials (UIDP/50011/2020)
Associated Laboratory CICECO-Aveiro Institute of Materials (LA/P/0006/2020)
acknowledgements
This work was developed within the scope of the project CICECO-Aveiro Institute of Materials, UIDB/50011/2020, UIDP/50011/2020 & LA/P/0006/2020, financed by national funds through the FCT/MCTES (PIDDAC) and when appropriate cofinanced by FEDER under the PT2020 Partnership Agreement. S. F. thanks FCT for her research contract (REF-069-88-ARH-2018), which is funded by national funds (OE), through FCT-Fundacao para a Ciencia e a Tecnologia, I.P., in the scope of the framework contract foreseen in the numbers 4, 5, and 6 of the article 23, of the Decree-Law 57/2016, of August 29, changed by Law 57/2017, of July 19.